Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Mental Health Disorders Up After Head […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Tumor Control Durable With Pembrolizumab in Merkel Cell […]
Read More
Infection causes one in five cancers throughout the world. Why do just seven human viruses cause...
Read More
Gene Expression Test Impacts Melanoma Management The DecisionDX-Melanoma is a 31-gene...
Read More
A recent study found that the accuracy of high-frequency ultrasound was similar to that of pathology for diagnosing basal cell and squamous cell carcinomas.
Read More
So-called ’dangling’ approvals get second look Over three days of meetings beginning...
Read More![[Immuno oncology treatment in head and neck cancer].](https://cdn.physiciansweekly.com/wp-content/uploads/2019/08/skin_cancer89.jpg)
In the near future, immunotherapy with checkpoint inhibitors will not only reach the relevant ENT...
Read More
Delayed Radiation Increases Breast Cancer Risk Recent study findings indicate that some...
Read More
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
